Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Pfaar

Showing results (1-10 of 306) with videos related to

Pageof 31
Sort By:
MMW Fortschritte Der Medizin|November 8, 2011
[Therapy possibilities and therapy chances: "cat sensitive patients should receive specialist immunotherapy" (interview by Robert Bublak)]Oliver Pfaar
Drug Research|November 17, 2020
Oliver Pfaar
Allergy|August 17, 2018
Sublingual immunotherapy with house dust mite tablets in children-The evidence-based journey of allergen immunotherapy proceedsOliver Pfaar
Current Opinion in Allergy and Clinical Immunology|May 4, 2006
Aspirin desensitization in aspirin intolerance: update on current standards and recent improvementsOliver Pfaar, Ludger Klimek
Expert Review of Clinical Immunology|May 3, 2013
A comparison of immunotherapy delivery methods for allergen immunotherapyLudger Klimek, Oliver Pfaar
Allergologie Select|April 14, 2023
Vaccination against infectious agents and allergen-specific immunotherapy: A critical analysisMargitta Worm, Oliver Pfaar
Allergy|January 12, 2021
Allergic reactions to COVID-19 vaccinations-unveiling the secret(s)Oliver Pfaar, Vera Mahler
MMW Fortschritte Der Medizin|June 9, 2011
[Cluster immunotherapy in allergic rhinoconjunctivitis]Ludger Klimek, Oliver Pfaar
Allergy|January 28, 2022
Novel adaptive design for allergen immunotherapy clinical trialsSergio Bonini, Oliver Pfaar
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 23, 2008
Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controlled trialOliver Pfaar, Ludger Klimek
Pageof 31

Showing results (1-10 of 306) with videos related to

Sort By:
Pageof 31
MMW Fortschritte Der Medizin|November 8, 2011
[Therapy possibilities and therapy chances: "cat sensitive patients should receive specialist immunotherapy" (interview by Robert Bublak)]Oliver Pfaar
Drug Research|November 17, 2020
Oliver Pfaar
Allergy|August 17, 2018
Sublingual immunotherapy with house dust mite tablets in children-The evidence-based journey of allergen immunotherapy proceedsOliver Pfaar
Current Opinion in Allergy and Clinical Immunology|May 4, 2006
Aspirin desensitization in aspirin intolerance: update on current standards and recent improvementsOliver Pfaar, Ludger Klimek
Expert Review of Clinical Immunology|May 3, 2013
A comparison of immunotherapy delivery methods for allergen immunotherapyLudger Klimek, Oliver Pfaar
Allergologie Select|April 14, 2023
Vaccination against infectious agents and allergen-specific immunotherapy: A critical analysisMargitta Worm, Oliver Pfaar
Allergy|January 12, 2021
Allergic reactions to COVID-19 vaccinations-unveiling the secret(s)Oliver Pfaar, Vera Mahler
MMW Fortschritte Der Medizin|June 9, 2011
[Cluster immunotherapy in allergic rhinoconjunctivitis]Ludger Klimek, Oliver Pfaar
Allergy|January 28, 2022
Novel adaptive design for allergen immunotherapy clinical trialsSergio Bonini, Oliver Pfaar
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 23, 2008
Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controlled trialOliver Pfaar, Ludger Klimek
Pageof 31